Steve Carter in his interview on wallstreet reporter said that they were seeing a "significant positive response" in their phase 1 trials against solid tumours . As far as I know , positive response is tumour shrinkage . If this is happening in the tiny doses of a phase 1 trial , then they have a something pretty special .